DTIC (NSC-45388) TOXICITYMOORE GE; MEISELBAUGH D.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 219Article

MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTICBUSCH, Christian; GEISLER, Jürgen; LILLEHAUG, Johan R et al.European journal of cancer (1990). 2010, Vol 46, Num 11, pp 2127-2133, issn 0959-8049, 7 p.Article

Fotosensibilidad por dacarbacina (DTIC) = Dacarbazine [DTIC]-induced photosensitivity reactionFERNANDEZ DE VILLATA, Maria José G; RUIZ-GENAO, Diana; SANCHEZ-PEREZ, Javier et al.Actas dermo-sifiliográficas (Ed. impresa). 2003, Vol 94, Num 8, pp 549-551, issn 0001-7310, 3 p.Article

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma : a randomized phase III trial of the DC study group of the DeCOGSCHADENDORF, D; UGUREL, S; ZIMPFER-RECHNER, C et al.Annals of oncology. 2006, Vol 17, Num 4, pp 563-570, issn 0923-7534, 8 p.Article

Changing concepts in the systemic treatment locally advanced or metastatic soft tissue sarcomasVERWEIJ, J; PINEDO, H. M.Cancer treatment and research. 1993, Vol 67, pp 107-116, issn 0927-3042Article

Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanomaSTABLES, G. I; DOHERTY, V. R; MACKIE, R. M et al.British journal of dermatology (1951). 1992, Vol 127, Num 5, pp 505-508, issn 0007-0963Article

Customer service and marketing at the Defense Technical Information CenterRYAN, R; COALGATE, B.Information services & use. 1990, Vol 10, Num 6, pp 371-379, issn 0167-5265, 9 p.Article

Influence of therapy on the antioxidant status in patients with melanomaGADJEVA, V; DIMOV, A; GEORGIEVA, N et al.Journal of clinical pharmacy and therapeutics (Print). 2008, Vol 33, Num 2, pp 179-185, issn 0269-4727, 7 p.Article

Re-evaluating the role of dacarbazine in metastatic melanoma : What have we learned in 30 years?EGGERMONT, Alexander M. M; KIRKWOOD, John M.European journal of cancer (1990). 2004, Vol 40, Num 12, pp 1825-1836, issn 0959-8049, 12 p.Article

NEW DRUG SEMINAR ON DTIC. 6. PROCEEDINGS; BETHESDA, MD.; 19751976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 2; PP. 123-214; BIBL. DISSEM.Conference Paper

1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC)FARQUHAR, D; BENVENUTO, J.Journal of medicinal chemistry (Print). 1984, Vol 27, Num 12, pp 1723-1727, issn 0022-2623Article

Cell-mediated immunity to chemically xenogenized tumors. VI: The effect of cell treatment with retroviral env antisense oligonucleotidesGROHMANN, U; BINAGLIA, L; PUCCETTI, P et al.International journal of immunopharmacology. 1993, Vol 15, Num 5, pp 567-572, issn 0192-0561Article